Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy

Table 1 Patient characteristics

	Number	Percentage
Gender
Male	32	82%
Female	8	18%
ECOG performance status1
0	21	55%
1	14	37%
2	3	8%
Etiology of hepatocellular carcinoma2
Hepatitis C	17	46%
Alcohol	8	22%
Combination of Hepatitis C/alcohol	8	22%
NASH	4	8%
BCLC Stage
0 (very early)	6	15%
A (early)	10	25%
B (intermediate)	24	60%
Previous treatment
None	34	85%
TACE	6	15%
Number of treated lesions
Single	32	80%
Multiple3	8	20%
Initial MELD score
< 10	31	78%
> 10	9	22%
Median tumor size (range)	3.5 cm	(1.5 to 8.9 cm)
Median gross tumor volume (range)	23 cc	(2.6 to 220.1 cc)
Median planning target volume (range)	67.6 cc	(11.5 to 351 cc)

¹2 patients unknown;

²1 patient with biliary cirrhosis and 1 immunosuppressed;

³7 patients with 2 lesions and 1 with 3 lesions. ECOG: Eastern cooperative oncology group; NASH: Non-alcoholic steatohepatitis; BCLC: Barcelona liver clinic; TACE: Transarterial chemo-embolization; MELD: Model for end stage liver disease.